医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

159 Regenerative Medicine Group Launches ‘Hong Kong Tour for Rebirth’

2014年03月19日 PM09:30
このエントリーをはてなブックマークに追加


 

HONG KONG

Hong Kong’s renowned 159 Regenerative Medicine Group, a group of life science experts specializing in aging and anti-aging and regenerative medicine, today announces its Hong Kong Tour for Rebirth, a week long trip to Hong Kong that will extend, protect and enhance the lives of those who take part.

Bringing the Group’s Nobel Prize-based iPS stem cell technology and its superior medical beauty and anti-aging healthcare services together with the beauty of Hong Kong – the Pearl of the Orient – the tour will offer participants a once-in-a-lifetime chance to enjoy an entirely new way of living. This incredible experience involves a course of Autologous Hematopoietic Stem Cell transplantation, followed by exposure to Hong Kong’s world-class landmarks and multinational cuisines.

Beginning with an introduction to the Group’s services at its state-of-the-art Anti-Aging Centre and with the participants’ health at the focus of every one of the seven days, the tour will be a professional and personalized anti-aging service, which will not only enhance the participants’ quality of life, but also prolong their lifespans.

Highlights of the tour include:

  • An anti-aging health care course including Autologous Hematopoietic Stem Cell transplantation;
  • Anti-aging report and health care guidance given by doctors and nutritionists;
  • Test on the functional aging of organs and tissue, and an overall aging test;
  • Autologous Stem Cell production and preservation;
  • Round trip ticket, Star level hotel accommodation, tour of Hong Kong and Macau landmarks, food and beverages.

The total value of this unique tour is HK $600,000. For a limited time, the tour is available at the preferential price of HK $390,000.

About the Group

159 Regenerative Medicine Group, a subsidiary of Hong Kong Life Sciences and Technologies Group Limited (Stock Code: 8085), has been developing and perfecting stem cell treatment methods for 15 years. Based on the Nobel Prize-based iPS stem cell technology, in 2012 the Group developed a series of Autologous Hematopoietic Stem Cell production, anti-aging and medical treatments, providing a “one-stop” service which protects, produces and preserves stem cells. The Group also offers professional medical consultation, GMP laboratory testing, application Autologous Hematopoietic Stem Cell technology, and several unique 360-degree human aging detection techniques to assess the aging process.

Hotline: 852-3588-0900

CONTACT

159 Regenerative Medicine Group
Miss Alison Fung, 852-3588-0928
alison.fung@159group.hk

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高